Cash & equivalents increased 20.2%
Cash & equivalents changed +20.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +20.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating income changed -13.4% from the comparable as-filed period.
Revenue changed -4.3% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Inventory / revenue changed +263 basis points from the comparable as-filed period.
Net income changed -11.2% from the comparable as-filed period.
Selling, general & administrative changed +5.7% from the comparable as-filed period.
Inventory changed -0.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Gross profit changed -1.0% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.